tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Neuphoria Therapeutics downgraded to Neutral from Buy at Lucid Capital
PremiumThe FlyNeuphoria Therapeutics downgraded to Neutral from Buy at Lucid Capital
4d ago
Closing Bell Movers: DocGo soars after SteadyMD deal
Premium
The Fly
Closing Bell Movers: DocGo soars after SteadyMD deal
4d ago
Neuphoria Therapeutics Ends SAD Program After Trial Failure
Premium
Company Announcements
Neuphoria Therapeutics Ends SAD Program After Trial Failure
4d ago
Neuphoria Therapeutics: Strong Cash Position and Promising Pipeline Drive Buy Rating
PremiumRatingsNeuphoria Therapeutics: Strong Cash Position and Promising Pipeline Drive Buy Rating
24d ago
Neuphoria Therapeutics price target raised to $35 from $18 at Maxim
Premium
The Fly
Neuphoria Therapeutics price target raised to $35 from $18 at Maxim
1M ago
Neuphoria Therapeutics completes target enrollment in Phase 3 AFFIRM-1 trial
Premium
The Fly
Neuphoria Therapeutics completes target enrollment in Phase 3 AFFIRM-1 trial
2M ago
Neuphoria Therapeutics to receive $15M payment from Merck
PremiumThe FlyNeuphoria Therapeutics to receive $15M payment from Merck
8M ago
Neuphoria Therapeutics price target raised to $21 from $8 at H.C. Wainwright
Premium
The Fly
Neuphoria Therapeutics price target raised to $21 from $8 at H.C. Wainwright
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100